Which has grown faster, FBIOP or HCAT?

Over the past five years, HCAT grew revenue faster — FBIOP at a 5.39% CAGR versus HCAT at 6.24%.

Is FBIOP or HCAT more profitable?

FBIOP runs the higher net margin — FBIOP at 163.32% versus HCAT at -90.61%.

How have FBIOP and HCAT total returns compared?

Over the past 5 years, FBIOP delivered 0.05% and HCAT delivered -48.35% annualized total return. Past performance doesn't predict future results.

Fortress Biotech, Inc. (FBIOP) vs Health Catalyst, Inc. (HCAT)

A side-by-side comparison of Fortress Biotech, Inc. and Health Catalyst, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

FBIOP

Fortress Biotech, Inc.

$140M

$17.75HealthcareDelayed quote: Oct 6, 2026, 10:53 AM EDT

HCAT

Health Catalyst, Inc.

$134M

$1.81HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — FBIOP vs HCAT

growth of $100 · dividends reinvested · last 7y

FBIOP +54.4% (+6.4%/yr)HCAT -95.5% (-35.8%/yr)FBIOP compounded faster over this window

Log scale — wide-divergence pair

FBIOP HCAT

FBIOP vs HCAT: by the numbers

•FBIOP is the larger company ($140M vs $134M market cap).
•FBIOP is profitable (163.32% net margin) while HCAT runs a net loss (-90.61%).
•HCAT grew revenue faster over the past five years (6.24% vs 5.39% CAGR).

Metrics side by side

Valuation

Metric	FBIOP	HCAT
P/E ratio	6.62	N/A
Forward P/E	6.96	N/A
P/S ratio	2.04	0.46
P/B ratio	0.85	1.32
EV / EBITDA	N/A	75.25
FCF yield	90.06%	9.78%

Profitability

Metric	FBIOP	HCAT
Gross margin	62.53%	33.47%
Operating margin	-111.00%	-11.60%
Net margin	163.32%	-90.61%
ROE	68.12%	-262.64%
ROIC	-10.85%	-21.42%

Growth (annualized)

Metric	FBIOP	HCAT
Revenue CAGR (5Y)	5.39%	6.24%
Total return CAGR (5Y)	0.05%	-48.35%

Frequently asked

Which has grown faster, FBIOP or HCAT?: Over the past five years, HCAT grew revenue faster — FBIOP at a 5.39% CAGR versus HCAT at 6.24%.
Is FBIOP or HCAT more profitable?: FBIOP runs the higher net margin — FBIOP at 163.32% versus HCAT at -90.61%.
How have FBIOP and HCAT total returns compared?: Over the past 5 years, FBIOP delivered 0.05% and HCAT delivered -48.35% annualized total return. Past performance doesn't predict future results.

Go deeper

Full FBIOP analysis Full HCAT analysis Interactive comparison tool

Dig into the metrics

Fortress Biotech P/E ratio Fortress Biotech ROE Health Catalyst ROE Fortress Biotech operating margin Health Catalyst operating margin Fortress Biotech revenue growth Health Catalyst revenue growth Fortress Biotech free cash flow Health Catalyst free cash flow

Fortress Biotech & Health Catalyst appear in these rankings

Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.